These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9927296)

  • 21. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.
    Wong WW; Tan MM; Xia Z; Dimitroulakos J; Minden MD; Penn LZ
    Clin Cancer Res; 2001 Jul; 7(7):2067-75. PubMed ID: 11448925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
    Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G
    Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.
    Zhong WB; Wang CY; Chang TC; Lee WS
    Endocrinology; 2003 Sep; 144(9):3852-9. PubMed ID: 12933658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway.
    Laezza C; Mazziotti G; Fiorentino L; Gazzerro P; Portella G; Gerbasio D; Carella C; Matarese G; Bifulco M
    J Mol Med (Berl); 2006 Nov; 84(11):967-73. PubMed ID: 16947002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Action of an HMG CoA reductase inhibitor, lovastatin, on apoptosis of untransformed and ts-SV40 transformed human smooth muscle cells derived from saphenous vein.
    Unlu S; Clunn G; Schachter M; Demoliou-Mason C; Hughes AD
    J Cardiovasc Pharmacol; 2001 Aug; 38(2):161-73. PubMed ID: 11483865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
    Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
    Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Roelofs AJ; Edwards CM; Russell RG; Ebetino FH; Rogers MJ; Hulley PA
    J Pharmacol Exp Ther; 2007 Jul; 322(1):228-35. PubMed ID: 17412884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of apoptosis by lovastatin through activation of caspase-3 and DNase II in leukaemia HL-60 cells.
    Wang IK; Lin-Shiau SY; Lin JK
    Pharmacol Toxicol; 2000 Feb; 86(2):83-91. PubMed ID: 10728920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of the HMG-CoA reductase inhibitor lovastatin and nitric oxide in cardiomyocyte cell death.
    Rabkin SW; Tsang MY
    Pharmacology; 2008; 82(1):74-82. PubMed ID: 18504415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis of medulloblastoma cells in vitro follows inhibition of farnesylation using manumycin A.
    Wang W; Macaulay RJ
    Int J Cancer; 1999 Jul; 82(3):430-4. PubMed ID: 10399961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis.
    Esemuede N; Lee T; Maier KG; Sumpio BE; Gahtan V
    J Surg Res; 2011 Jun; 168(1):149-54. PubMed ID: 20338582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.
    Lobell RB; Omer CA; Abrams MT; Bhimnathwala HG; Brucker MJ; Buser CA; Davide JP; deSolms SJ; Dinsmore CJ; Ellis-Hutchings MS; Kral AM; Liu D; Lumma WC; Machotka SV; Rands E; Williams TM; Graham SL; Hartman GD; Oliff AI; Heimbrook DC; Kohl NE
    Cancer Res; 2001 Dec; 61(24):8758-68. PubMed ID: 11751396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-cycle gene expression in lovastatin-induced medulloblastoma apoptosis.
    Wang W; Macaulay RJ
    Can J Neurol Sci; 2003 Nov; 30(4):349-57. PubMed ID: 14672267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.
    Gamen S; Anel A; Pérez-Galán P; Lasierra P; Johnson D; Piñeiro A; Naval J
    Exp Cell Res; 2000 Jul; 258(1):223-35. PubMed ID: 10912804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer.
    Kaneko R; Tsuji N; Asanuma K; Tanabe H; Kobayashi D; Watanabe N
    J Biol Chem; 2007 Jul; 282(27):19273-81. PubMed ID: 17472962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lovastatin-induced cardiac toxicity involves both oncotic and apoptotic cell death with the apoptotic component blunted by both caspase-2 and caspase-3 inhibitors.
    Rabkin SW; Kong JY
    Toxicol Appl Pharmacol; 2003 Dec; 193(3):346-55. PubMed ID: 14678744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome.
    Efuet ET; Keyomarsi K
    Cancer Res; 2006 Jan; 66(2):1040-51. PubMed ID: 16424040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HMG-CoA reductase inhibitors induce apoptosis in mouse proximal tubular cells in primary culture.
    Iimura O; Vrtovsnik F; Terzi F; Friedlander G
    Kidney Int; 1997 Oct; 52(4):962-72. PubMed ID: 9328935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of farnesylation blocks growth but not differentiation in FRTL-5 thyroid cells.
    Bifulco M; Laezza C; Aloj SM
    Biochimie; 1999 Apr; 81(4):287-90. PubMed ID: 10401660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.